Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals

Journal of Hypertension

Volumn 29, Issue 3, 2011, Pages 553-564

  Straznicky, Nora E ^a   Grima, Mariee T ^a   Lambert, Elisabeth A ^a   Eikelis, Nina ^b   Dawood, Tye ^a   Lambert, Gavin W ^a   Nestel, Paul J ^c   Masuo, Kazuko ^a   Sari, Carolina I ^a   Chopra, Reena ^a   Mariani, Justin A ^d   Schlaich, Markus P ^b  

^a Human Neurotransmitters   (Australia)

^b Neurovascular Hypertension and Kidney Disease   (Australia)

^c Cardiovascular Nutrition   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

aerobic exercise; albuminuria; metabolic syndrome; obesity; renal function; sympathetic nervous system; weight loss

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CREATININE; URIC ACID;

ADULT; AEROBIC EXERCISE; ALBUMINURIA; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIET; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; LIFESTYLE MODIFICATION; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; NERVE CONDUCTION; OBESITY; OXYGEN CONSUMPTION; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC NERVE; TREATMENT RESPONSE; URINARY EXCRETION; WEIGHT REDUCTION;

EID: 79951589311     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283418875     Document Type: Article

References (53)

1. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28:1769-1778. (Pubitemid 40923091)
2. Alebiosu CO, Ayodele OE. The global burden of chronic kidney disease and the way forward. Ethn Dis 2005; 15:418-423. (Pubitemid 41245551)
3. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140:167-174.
4. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16:2134-2140. (Pubitemid 41716445)
5. Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Hirakata H, Lida M. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006; 48:383-391. (Pubitemid 44247252)
6. Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009; 53:59-69.
7. Sarafidis PA. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Curr Opin Nephrol Hypertens 2008; 17:450-456.
8. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, et al. Neuroadrenergic and reflex abnormalities in patients with the metabolic syndrome. Diabetologia 2005; 48:1359-1365. (Pubitemid 41186102)
9. Straznicky N, Eikelis N, Lambert E, Esler M. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 2008; 10:440-447.
10. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96:3423-3429. (Pubitemid 27513415)
11. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, et al. Sympathetic activation in chronic renal failure: causes, consequences and therapeutic implications. J Am Soc Nephrol 2009; 20:933-939.
12. Masuo K, Katsuya T, Sugimoto K, Kawaguchi H, Rakugi H, Ogihara T, Tuck ML. High plasma norepinephrine levels associated with (-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals. Hypertens Res 2007; 30:503-511. (Pubitemid 47083120)
13. Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler DM, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiovascular risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90:5998-6005. (Pubitemid 41606517)
14. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome. Circulation 2008; 118:346-354.
15. Chagnac A, Weinstein T, Herman M, Hirsch J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14:1480-1486. (Pubitemid 36687049)
16. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009; 4:1565-1574.
17. Afshinnia F, Wilt TJ, Duval S, Esmaeli A, Ibrahim HN. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010; 25:1173-1183.
18. Pechter U, Ots M, Mesikepp S, Zilmer K, Kullissaar T, Vihalemm T, et al. Beneficial effects of water-based exercise in patients with chronic kidney disease. Int J Rehab Res 2003; 26:153-156. (Pubitemid 36819942)
19. Leehey DJ, Moinuddin I, Bast JP, Qureshi S, Jelinek CS, Cooper C, et al. Aerobic exercise in obese diabetic patients with chronic kidney diseases: a randomized controlled pilot study. Cardiovasc Diabetol 2009; 8:62-69.
20. Dengel DR, Brown MD, Reynolds TH IV, Supiano MA. Effect of aerobic exercise training on renal responses to sodium in hypertensives. Med Sci Sports Exerc 2006; 38:217-222. (Pubitemid 43271570)
21. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336:1117-1124.
22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112:2735-2752. (Pubitemid 41532612)
23. Straznicky NE, Lambert EA, Nestel PJ, McGrane M, Dawood T, Schlaich M, et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 2010; 59:71-79.
24. Poehlman ET, LaChance P, Tremblay A, Nadeau A, Dussault J, Theriault G, et al. The effect of prior exercise and caffeine ingestion on metabolic rate and hormones in young adult males. Can J Physiol Pharmacol 1989; 67:10-16. (Pubitemid 19068106)
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
26. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003; 14:2573-2580. (Pubitemid 37169342)
27. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D. A more accurate methodtoestimate glomerularfiltration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470. (Pubitemid 29135798)
28. Parati G, Saul JP, Castiglioni P. Assessing arterial baroreflex control of heart rate: new perspectives. J Hypertens 2004; 22:1259-1263. (Pubitemid 38888069)
29. Paradisi G, Smith L, Burtner C, Leaming R, Garvey WT, Hook G, et al. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 1999; 22:1310-1317. (Pubitemid 29350242)
30. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999; 22:1462-1470.
31. Moinuddin I, Leehey DJ. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chron Kid Dis 2008; 15:83-96. (Pubitemid 350278582)
32. Svarstad E, Myking O, Ofstad J, Iversen BM. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease. Scand J Urol Nephrol 2002; 36:464-472. (Pubitemid 36169508)
33. Chapman CB, Henschel A, Minckler J, Forsgren A, Keys A. The effect of exercise on renal plasma flow in normal male subjects. J Clin Invest 1948; 27:639-644.
34. Meredith IT, Friberg P, Jennings GL, Dewar EM, Fazio VA, Lambert GW, Esler MD. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 1991; 18:575-582.
35. Kohno K, Matsuoka H, Takenaka K, Miyake Y, Nomura G, Imaizumi T. Renal depressor mechanisms of physical training in patients with essential hypertension. Am J Hypertens 1997; 10:859-868. (Pubitemid 27380950)
36. Jennings G, Nelson L, Nestel P, Esler M, Korner P, Burton D, Bazelmans J. The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation 1986; 73:30-40. (Pubitemid 16132409)
37. DiBona GF. Neural control of renal function: cardiovascular implications. Hypertension 1989; 13:539-548.
38. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 1996; 491:881-887. (Pubitemid 26107257)
39. Brinkworth GD, Buckley JD, Noakes M, Clifton PM. Renalfunction following long-term weight loss in individuals with abdominal obesity on a very-low carbohydrate diet versus high carbohydrate diet. J Am Diet Assoc 2010; 110:633-638.
40. Straznicky N, Grassi G, Esler M, Lambert G, Dixon J, Lambert E, et al., for the European Society of Hypertension Working Group on Obesity and the Australian and New Zealand Obesity Society. Antihypertensive effects of weight loss: myth or reality? J Hypertens 2010; 28:637-643.
41. Laaksonen DE, Laitinen T, Schonberg J, Rissanen A, Niskanen LK. Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome. J Hypertens 2003; 21:371-378. (Pubitemid 36269709)
42. Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycaemic index diet on glycaemic control in type 2 diabetes mellitus. Nutr Metab 2008; 5:36.
43. Bagby SP. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? J Am Soc Nephrol 2004; 15:2775-2779.
44. Anderson EA, Hoffman RP, Balcon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87:2246-2252.
45. Cubeddu LX, Alfieri AB, Hoffman IS. Lowering the threshold for defining microalbuminuria: Effects of a lifestyle-metformin intervention in obese 'normoalbuminuric' nondiabetic subjects. Am J Hypertens 2008; 21:105-110.
46. Bello AK, De Zeeuw D, El Nahas M, Brantsma AH, Bakker SJL, DeJong PE, et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 2007; 22:1619-1627. (Pubitemid 47073760)
47. DeBoer IH, Astor BC, Kramer H, Palmas W, Rudser K, Seliger SL, et al. Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008; 197:407-414. (Pubitemid 351273262)
48. Ott C, Schlaich MP, Schmidt BM, Titze SI, Schaufele T, Schmieder RE. Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia. Atherosclerosis 2008; 196:704-711.
49. Lin J, Hu FB, Curhan GC. Association of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol 2010; 5:836-843.
50. Stuveling EM, Hillege HL, Bakker SJL, Gans ROB, DeJong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a nondiabetic population. Kidney Int 2003; 63:654-661. (Pubitemid 36126812)
51. Gulcan E, Gulcan A, Erliben E, Taser F, Sahin L, Ozbek O, et al. The predictive value of CRP levels on future severe renal disease in overweight and obese subjects without diabetes mellitus and hypertension. Am J Med Sci 2007; 334:444-451.
52. Dawood T, Schlaich MP. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation. Minerva Cardioangiol 2009; 57:687-704.
53. Ferder L, Inserra F, Martinez-Maldonado M. Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress. Curr Hypertens Rep 2006; 8:191-198. (Pubitemid 43853445)